Good to hear from you again. It's been quite awhile, and I thought you may have given up on RCPIQ. Ironic though, that we have been looking at the same info, but have reached opposite conclusions.
It has been a year now since the Chapter 7 filing, and yet nothing has been done to settle the case. That led me to conclude that the filing was strictly to stop the hemorrhaging of shares, and would have had to been agreed to by all parties involved.
Also, I believe that Dr. Mullan has been sincere in his dealings as CEO of RCPI, but for whatever reason, the door has been slammed shut on the development of anatabine as a medication. I also expect that the Phase 3 NILVAD STUDY results will be positive, and will launch the possibility of Archer and Rock Creek merging, leading to the further development of the anatabine potential we have long been aware of! It sickens me to realize that anatabine could have lessened the suffering of millions, especially the aging population like myself.
The only significant negative I have ever seen about anatabine is that it was unable to make young and healthy individuals any younger or healthier. Yet many dozens of studies have presented ailments that seem ideal for anatabine treatment. Here's hoping it ends well!
